The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to ...

The calls come thick and fast to Mumbai-based diabetologist Rahul Baxi - but not just from patients struggling to control blood sugar. Increasingly, it is young professionals asking the same thing: ...

Indian drugmakers are required to conduct animal toxicity studies in several categories where regulators in the US and Europe allow waivers or non-animal alternatives, an industry-backed report ...

On any given morning in Mumbai’s Shivaji Park, power-walkers circle the running track, fitness watches buzzing with every step. Minutes later, some drift toward nearby food stalls, where oil sizzles ...

HYDERABAD, India, Dec 24 (Reuters) - Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming ‌obesity drug market before cheaper generic versions hit ...

Wegovy's price cut follows Mounjaro's success in India India key market for Novo Nordisk and Eli Lilly's obesity drugs Wegovy's semaglutide patent expires in India in March 2026 BENGALURU, Nov 11 ...

(This was originally published in the India File newsletter, which is issued every Tuesday. Sign up here to get the latest news from India and how it matters to the world.) India has joined the global ...

WASHINGTON, DC – US lawmakers renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid-19 pandemic by India ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building an international knockoff drug powerhouse and has become one of the world’s most ...